Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lymph Node Microenvironment Modifications in Patients with CLL Treated with Venetoclax-based Regimens
2024-515938-32-00Phase 4Suspended
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of venetoclax in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), sponsored by IRCCS Ospedale San Raffaele. Started Nov 2024; status: suspended.
02
Drugs
venetoclax
03
Conditions
chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
Beyond the preview
Go deeper on 2024-515938-32-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-515938-32-00.